BOSTON, Mass. — Carna Health said it has raised $8 million to expand global access to its digital chronic kidney disease screening and care platform, as the company moves to scale its technology following a strategic partnership with Siemens Healthineers.
The financing included participation from Dr. Jay Rosan, Cenk Bekmezçi, Jose Pereyra, Mark Boulding, Brandon Salomon, Andrew Roosevelt, Jeff Lindsey, Joseph White, John Brooks, Elvis Ndansi, and Dr. Salvatore Viscomi.
“This funding enables us to continue global expansion, offering a transformative digital health platform that expands access to comprehensive chronic kidney disease care,” said Salvatore Viscomi, M.D., chief executive officer of Carna Health. “By integrating AI-driven solutions for early identification, monitoring, and patient management, we’re empowering patients and healthcare providers to navigate care pathways more effectively.”
The raise follows Carna Health’s recent strategic agreement with Siemens Healthineers to broaden access to preventive kidney care worldwide. The partnership combines Carna Health’s digital platform with Siemens Healthineers’ point-of-care diagnostics infrastructure to support large-scale screening initiatives. Alongside Siemens Healthineers and NeoDocs, Carna Health recently completed a screening program in Cameroon that enrolled 35,000 individuals across the Southwest and Littoral regions.
According to the company, data from its chronic kidney disease screening programs show that large-scale, cost-effective screening can uncover widespread, previously undiagnosed disease and create opportunities for earlier intervention. Carna Health said these findings reinforce its strategy to expand screening programs to additional regions globally.
“Chronic diseases present significant challenges, including late diagnoses and inadequate management,” said Dr. Jay Rosan. “This funding will enable us to accelerate Carna Health’s mission to provide effective, accessible tools that empower both patients and healthcare clinicians to tackle these challenges head-on. Our goal is to show that Carna Health’s platform can be seamlessly implemented worldwide and integrated with any health system, ensuring we reach as many people as possible.”
Carna Health said it plans to launch multiple programs in the Philippines in partnership with major cities and healthcare systems, with a national initiative also in development in the Dominican Republic. The company also intends to expand into the United States and Turkey.
“Reliable distribution and operational readiness are fundamental to the success of population health programs,” said Cenk Bekmezçi, an investor in the company. “Carna Health has developed a robust platform that functions effectively across diverse markets and infrastructure levels. Reaching this funding milestone enables a more coordinated, scalable approach to chronic disease management. We are pleased to partner with Carna Health to introduce this innovative solution to the Turkish market.”
Carna Health said its work in kidney health innovation has received international recognition, including selection for a United Nations-supported AI for Good publication, inclusion in the textbook Innovations in Nephrology: Breakthrough Technologies in Kidney Disease Care, and recognition as a finalist in the Fierce Life Sciences Innovation Awards.
